Prepubertal angiotensin blockade exerts long-term therapeutic effect through sustained ATRAP activation in salt-sensitive hypertensive rats

Journal of Hypertension

Volumn 29, Issue 10, 2011, Pages 1919-1929

  Dejima, Toru ^a   Tamura, Kouichi ^a   Wakui, Hiromichi ^a   Maeda, Akinobu ^a   Ohsawa, Masato ^a   Kanaoka, Tomohiko ^a   Haku, Sona ^a   Kengo, Azushima ^a   Masuda, Shin Ichiro ^a   Shigenaga, Atsu Ichiro ^a   Azuma, Koichi ^a   Matsuda, Miyuki ^a   Yabana, Machiko ^a   Hirose, Tomonori ^b   Uchino, Kazuaki ^a   Kimura, Kazuo ^a   Nagashima, Yoji ^b   Umemura, Satoshi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Angiotensin receptors; Basic science; Gene expression regulation; Hypertension (kidney); Oxidative stress (kidney); Receptors; Salt sensitive

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; AT1R ASSOCIATED PROTEIN; COLLAGEN TYPE 1; FIBRONECTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; OLMESARTAN; P22PHOX PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REGULATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; AGTRAP PROTEIN, RAT; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR; IMIDAZOLE DERIVATIVE; RENIN; TETRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DAHL SALT SENSITIVE RAT; DRUG EFFECT; HYPERTENSION; KIDNEY FIBROSIS; KIDNEY INJURY; MALE; NEPHRITIS; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREPUBERTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BLOCKING; SALT LOADING; UPREGULATION; ANIMAL; BLOOD PRESSURE; KIDNEY; METABOLISM; PATHOLOGY; SALT INTAKE; SEXUAL MATURATION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BLOOD PRESSURE; HYPERTENSION; IMIDAZOLES; KIDNEY; MALE; OXIDATIVE STRESS; RATS; RATS, INBRED DAHL; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RENIN; SEXUAL MATURATION; SODIUM CHLORIDE, DIETARY; TETRAZOLES;

EID: 84856018733     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32834a5a46     Document Type: Article

References (49)

1. Geleijnse JM, Hofman A, Witteman JC, Hazebroek AA, Valkenburg HA, Grobbee DE. Long-term effects of neonatal sodium restriction on blood pressure. Hypertension 1997;29:913-917. (Pubitemid 27152458)
2. Tekol Y. Irreversible and reversible components in the genesis of hypertension by sodium chloride (salt). Med Hypotheses 2008;70:255-259. (Pubitemid 350297622)
3. Dahl LK, Knudsen KD, Heine MA, Leitl GJ. Effects of chronic excess salt ingestion. Modification of experimental hypertension in the rat by variations in the diet. Circ Res 1968;22:11-18.
4. Zicha J, Kunes J, Jelinek J. Experimental hypertension in young and adult animals. Hypertension 1986;8:1096-1104. (Pubitemid 17228779)
5. Kawarazaki H, Ando K, Nagae A, Fujita M, Matsui H, Fujita T. Mineralocorticoid receptor activation contributes to salt-induced hypertension and renal injury in prepubertal Dahl salt-sensitive rats. Nephrol Dial Transplant 2010;25:2879-2889.
6. Tamura K, Chiba E, Yokoyama N, Sumida Y, Yabana M, Tamura N, et al. Renin-angiotensin system and fibronectin gene expression in Dahl Iwai salt-sensitive and salt-resistant rats. J Hypertens 1999;17:81-89. (Pubitemid 29086192)
7. Liang B, Leenen FH. Prevention of salt induced hypertension and fibrosis by angiotensin converting enzyme inhibitors in Dahl S rats. Br J Pharmacol 2007;152:903-914. (Pubitemid 350100499)
8. Zhu A, Yoneda T, Demura M, Karashima S, Usukura M, Yamagishi M, et al. Effect of mineralocorticoid receptor blockade on the renal renin-angiotensin system in Dahl salt-sensitive hypertensive rats. J Hypertens 2009;27:800-805.
9. Welch WJ, Blau J, Xie H, Chabrashvili T, Wilcox CS. Angiotensin-induced defects in renal oxygenation: role of oxidative stress. Am J Physiol Heart Circ Physiol 2005;288:H22-H28. (Pubitemid 40023823)
10. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007;292:C82-C97. (Pubitemid 46127306)
11. Ruiz-Ortega M, Esteban V, Ruperez M, Sanchez-Lopez E, Rodriguez-Vita J, Carvajal G, et al. Renal and vascular hypertension-induced inflammation: role of angiotensin II. Curr Opin Nephrol Hypertens 2006;15:159-166.
12. Garrido AM, Griendling KK. NADPH oxidases and angiotensin II receptor signaling. Mol Cell Endocrinol 2009;302:148-158.
13. Daviet L, Lehtonen JY, Tamura K, Griese DP, Horiuchi M, Dzau VJ. Cloning and characterization of ATRAP, a novel protein that interacts with the angiotensin II type 1 receptor. J Biol Chem 1999;274:17058-17062.
14. Lopez-Ilasaca M, Liu X, Tamura K, Dzau VJ. The angiotensin II type I receptor-associated protein, ATRAP, is a transmembrane protein and a modulator of angiotensin II signaling. Mol Biol Cell 2003;14:5038-5050. (Pubitemid 37484817)
15. Tanaka Y, Tamura K, Koide Y, Sakai M, Tsurumi Y, Noda Y, et al. The novel angiotensin II type 1 receptor (AT1R)-associated protein ATRAP downregulates AT1R and ameliorates cardiomyocyte hypertrophy. FEBS Lett 2005;579:1579-1586. (Pubitemid 40341526)
16. Azuma K, Tamura K, Shigenaga A, Wakui H, Masuda S, Tsurumi-Ikeya Y, et al. Novel regulatory effect of angiotensin II type 1 receptor-interacting molecule on vascular smooth muscle cells. Hypertension 2007;50:926-932. (Pubitemid 350287536)
17. Mogi M, Iwai M, Horiuchi M. Emerging concepts of regulation of angiotensin II receptors: new players and targets for traditional receptors. Arterioscler Thromb Vasc Biol 2007;27:2532-2539. (Pubitemid 350158902)
18. Tamura K, Tanaka Y, Tsurumi Y, Azuma K, Shigenaga A, Wakui H, et al. The role of angiotensin AT1 receptor-associated protein in renin-angiotensin system regulation and function. Curr Hypertens Rep 2007;9:121-127. (Pubitemid 46779376)
19. Shigenaga A, Tamura K, Wakui H, Masuda S, Azuma K, Tsurumi-Ikeya Y, et al. Effect of olmesartan on tissue expression balance between angiotensin II receptor and its inhibitory binding molecule. Hypertension 2008;52:672-678.
20. Wakui H, Tamura K, Matsuda M, Bai Y, Dejima T, Shigenaga A, et al. Intrarenal suppression of angiotensin II type 1 receptor binding molecule in angiotensin II-infused mice. Am J Physiol Renal Physiol 2010;299:F991-F1003.
21. Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 2006;354:1685-1697.
22. Nakaya H, Sasamura H, Hayashi M, Saruta T. Temporary treatment of prepubescent rats with angiotensin inhibitors suppresses the development of hypertensive nephrosclerosis. J Am Soc Nephrol 2001;12:659-666. (Pubitemid 32246693)
23. Nakaya H, Sasamura H, Mifune M, Shimizu-Hirota R, Kuroda M, Hayashi M, et al. Prepubertal treatment with angiotensin receptor blocker causes partial attenuation of hypertension and renal damage in adult Dahl saltsensitive rats. Nephron 2002;91:710-718. (Pubitemid 34914076)
24. Tamura K, Umemura S, Nyui N, Yamakawa T, Yamaguchi S, Ishigami T, et al. Tissue-specific regulation of angiotensinogen gene expression in spontaneously hypertensive rats. Hypertension 1996;27:1216-1223. (Pubitemid 26165622)
25. Tsurumi Y, Tamura K, Tanaka Y, Koide Y, Sakai M, Yabana M, et al. Interacting molecule of AT1 receptor, ATRAP, is colocalized with AT1 receptor in the mouse renal tubules. Kidney Int 2006;69:488-494. (Pubitemid 43164440)
26. Wakui H, Tamura K, Tanaka Y, Matsuda M, Bai Y, Dejima T, et al. Cardiacspecific activation of angiotensin II type 1 receptor-associated protein completely suppresses cardiac hypertrophy in chronic angiotensin II-infused mice. Hypertension 2010;55:1157-1164.
27. Masuda S, Tamura K, Wakui H, Maeda A, Dejima T, Hirose T, et al. Expression of angiotensin II type 1 receptor-interacting molecule in normal human kidney and IgA nephropathy. Am J Physiol Renal Physiol 2010;299:F720-F731.
28. Sakai M, Tamura K, Tsurumi Y, Tanaka Y, Koide Y, Matsuda M, et al. Expression of MAK-V/Hunk in renal distal tubules and its possible involvement in proliferative suppression. Am J Physiol Renal Physiol 2007;292:F1526-F1536. (Pubitemid 46701880)
29. Sasamura H, Hayashi K, Ishiguro K, Nakaya H, Saruta T, Itoh H. Prevention and regression of hypertension: role of renal microvascular protection. Hypertens Res 2009;32:658-664.
30. Gillies LK, Lu M, Wang H, Lee RM. AT1 receptor antagonist treatment caused persistent arterial functional changes in young spontaneously hypertensive rats. Hypertension 1997;30:1471-1478. (Pubitemid 27528091)
31. Ishiguro K, Sasamura H, Sakamaki Y, Itoh H, Saruta T. Developmental activity of the renin-angiotensin system during the 'critical period' modulates later L-NAME-induced hypertension and renal injury. Hypertens Res 2007;30:63-75.
32. Etoh T, Inoguchi T, Kakimoto M, Sonoda N, Kobayashi K, Kuroda J, et al. Increased expression of NAD (P) H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment. Diabetologia 2003;46:1428-1437. (Pubitemid 37297214)
33. Kitiyakara C, Chabrashvili T, Chen Y, Blau J, Karber A, Aslam S, et al. Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase. J Am Soc Nephrol 2003;14:2775-2782. (Pubitemid 37305640)
34. Gill PS, Wilcox CS. NADPH oxidases in the kidney. Antioxid Redox Signal 2006;8:1597-1607. (Pubitemid 44726334)
35. Djamali A, Vidyasagar A, Adulla M, Hullett D, Reese S. Nox-2 is a modulator of fibrogenesis in kidney allografts. Am J Transplant 2009;9:74-82.
36. Li N, Yi FX, Spurrier JL, Bobrowitz CA, Zou AP. Production of superoxide through NADH oxidase in thick ascending limb of Henle's loop in rat kidney. Am J Physiol Renal Physiol 2002;282:F1111-F1119. (Pubitemid 34654477)
37. Mori T, Cowley AW Jr. Angiotensin II-NAD (P) H oxidase-stimulated superoxide modifies tubulovascular nitric oxide cross-talk in renal outer medulla. Hypertension 2003;42:588-593. (Pubitemid 37237358)
38. Wilcox CS. Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am J Physiol Regul Integr Comp Physiol 2005;289:R913-R935. (Pubitemid 41397037)
39. Polichnowski AJ, Cowley AW Jr. Pressure-induced renal injury in angiotensin II versus norepinephrine-induced hypertensive rats. Hypertension 2009;54:1269-1277.
40. Kobori H, Nishiyama A, Abe Y, Navar LG. Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension 2003;41:592-597. (Pubitemid 36314637)
41. Nishiyama A, Yoshizumi M, Rahman M, Kobori H, Seth DM, Miyatake A, et al. Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats. Kidney Int 2004;65:972-981. (Pubitemid 38251073)
42. Chabrashvili T, Kitiyakara C, Blau J, Karber A, Aslam S, Welch WJ, et al. Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am J Physiol Regul Integr Comp Physiol 2003;285:R117-R124. (Pubitemid 36736508)
43. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, et al. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci USA 2006;103:17985-17990. (Pubitemid 44852272)
44. Chandramohan G, Bai Y, Norris K, Rodriguez-Iturbe B, Vaziri ND. Effects of dietary salt on intrarenal angiotensin system, NAD (P) H oxidase, COX-2, MCP-1 and PAI-1 expressions and NF-kappaB activity in salt-sensitive and -resistant rat kidneys. Am J Nephrol 2008;28:158-167. (Pubitemid 350126507)
45. Zalba G, San Jose G, Moreno MU, Fortuno MA, Fortuno A, Beaumont FJ, et al. Oxidative stress in arterial hypertension: role of NAD (P) H oxidase. Hypertension 2001;38:1395-1399. (Pubitemid 34033422)
46. Weber DS, Rocic P, Mellis AM, Laude K, Lyle AN, Harrison DG, et al. Angiotensin II-induced hypertrophy is potentiated in mice overexpressing p22phox in vascular smooth muscle. Am J Physiol Heart Circ Physiol 2005;288:H37-H42. (Pubitemid 40023825)
47. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007;87:245-313. (Pubitemid 46209993)
48. Padia SH, Howell NL, Siragy HM, Carey RM. Renal angiotensin type 2 receptors mediate natriuresis via angiotensin III in the angiotensin II type 1 receptor-blocked rat. Hypertension 2006;47:537-544. (Pubitemid 43843872)
49. Carey RM, Padia SH. Angiotensin AT2 receptors: control of renal sodium excretion and blood pressure. Trends Endocrinol Metab 2008;19:84-87. (Pubitemid 351442917)